These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33147653)

  • 1. Osteoblasts/Osteocytes sirtuin6 Is Vital to Preventing Ischemic Osteonecrosis Through Targeting VDR-RANKL Signaling.
    Zhang Z; Song Y; Wang SI; Ha SH; Jang KY; Park BH; Moon YJ; Kim JR
    J Bone Miner Res; 2021 Mar; 36(3):579-590. PubMed ID: 33147653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Sirtuin 6 in osteoblast lineage cells activates osteoclasts, resulting in osteopenia.
    Kim SJ; Piao Y; Lee MG; Han AR; Kim K; Hwang CJ; Seo JT; Moon SJ
    Bone; 2020 Sep; 138():115497. PubMed ID: 32599221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocyte RANKL Drives Bone Resorption in Mouse Ligature-Induced Periodontitis.
    Kittaka M; Yoshimoto T; Levitan ME; Urata R; Choi RB; Teno Y; Xie Y; Kitase Y; Prideaux M; Dallas SL; Robling AG; Ueki Y
    J Bone Miner Res; 2023 Oct; 38(10):1521-1540. PubMed ID: 37551879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
    Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
    J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
    Kim HK; Morgan-Bagley S; Kostenuik P
    J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
    Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
    Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice Femurs.
    Cabahug-Zuckerman P; Frikha-Benayed D; Majeska RJ; Tuthill A; Yakar S; Judex S; Schaffler MB
    J Bone Miner Res; 2016 Jul; 31(7):1356-65. PubMed ID: 26852281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for excessive osteoclast activation in SIRT6 null mice.
    Zhang D; Jing J; Lou F; Li R; Ping Y; Yu F; Wu F; Yang X; Xu R; Li F; Wang K; Bai M; Pi C; Xie J; Zheng L; Ye L; Zhou X
    Sci Rep; 2018 Jul; 8(1):10992. PubMed ID: 30030453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic Osteocytes Induce RANKL Production in Bystanders via Purinergic Signaling and Activation of Pannexin Channels.
    McCutcheon S; Majeska RJ; Spray DC; Schaffler MB; Vazquez M
    J Bone Miner Res; 2020 May; 35(5):966-977. PubMed ID: 31910292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
    Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
    J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis-A therapeutic implication in inflammatory bone resorption.
    Hou KL; Lin SK; Chao LH; Hsiang-Hua Lai E; Chang CC; Shun CT; Lu WY; Wang JH; Hsiao M; Hong CY; Kok SH
    Biofactors; 2017 Mar; 43(2):170-180. PubMed ID: 27534902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
    Li JY; Yu M; Tyagi AM; Vaccaro C; Hsu E; Adams J; Bellido T; Weitzmann MN; Pacifici R
    J Bone Miner Res; 2019 Feb; 34(2):349-360. PubMed ID: 30399207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
    Kassem A; Lindholm C; Lerner UH
    PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in bone resorption regulated by vitamin D.
    Nakamichi Y; Udagawa N; Suda T; Takahashi N
    J Steroid Biochem Mol Biol; 2018 Mar; 177():70-76. PubMed ID: 29146302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts.
    Kassem A; Henning P; Lundberg P; Souza PP; Lindholm C; Lerner UH
    J Biol Chem; 2015 Aug; 290(33):20147-58. PubMed ID: 26085099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
    Thouverey C; Caverzasio J
    Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.